期刊文献+

胶体金法N-末端脑钠肽检测在呼吸困难患者中的临床应用

下载PDF
导出
摘要 目的探讨胶体金法快速检测N-末端脑钠肽在临床的应用价值。方法选取2011年2月至2012年10月在该院就诊的51例心源性呼吸困难患者和63例非心源性呼吸困难患者及60例健康体检者,采用胶体金法定量检测上述人群血浆中的N-末端脑钠肽水平,进行统计分析。结果 51例心源性呼吸困难患者血浆N-末端脑钠肽水平升高,而63例非心源性呼吸困难患者未出现升高,差异有统计学意义(P<0.05)。结论胶体金法N-末端脑钠肽检测适用实验室检测及床旁检测,且具有简单、快捷、敏感性和特异性较高的特点。
作者 耿伏生
出处 《国际检验医学杂志》 CAS 2013年第16期2154-2155,共2页 International Journal of Laboratory Medicine
  • 相关文献

参考文献7

  • 1Januzzi JL, Camargo CA, Anwaruddin S, et al. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study[J]. Am J Cardiol,2005,95(8) :948-954.
  • 2Hammerer-Lercher A, Neubauer E, Muller S, et al. Head-to-headcomparison of N-terminal pro-BNP, BNP and Nt-ANP in diagnosis left wentricular dysfunction [J]. Clim Aeta, 2001,310 (2) : 193- 197.
  • 3Mueller T,Gegenhuber A, Poelz W, et al. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emer gency diagnosis of heart failure[J]. Heart, 2005,91(5) :606-612.
  • 4Januzzi JL, van Kimmenade R, Lainehbury J, et al. NT-proBNP testing for diagnosis and short-term prognosis in acute destabi- lized heart failure, an international pooled analysis of 1256 pa- tients the International Collaborative of NT proBNP Study[J]. Eur Heart J,2006,27(3) ,330-337.
  • 5Kragelund C.,Grφnning B.,Kφber L.,赵和平.稳定型冠心病患者其N-末端前B型脑钠肽与远期死亡率的关系[J].世界核心医学期刊文摘(心脏病学分册),2005,0(7):24-25. 被引量:37
  • 6Rodseth RN. B type natriuretic peptide-a diagnostic break- through in peri-operative cardiac risk assessment[J]. Anaesthesi- a,2009,64(2) 165-178.
  • 7张丽,张春玲,丛祥凤,张健,陈曦.N末端B型钠尿肽原和大内皮素-1对严重心力衰竭患者的预后作用及其与心血管病关系的研究[J].中华检验医学杂志,2007,30(11):1237-1241. 被引量:12

二级参考文献11

  • 1史晓敏,徐国宾,夏铁安.N末端B型钠尿肽原对充血性心力衰竭患者预后及危险分层评价的价值[J].中华检验医学杂志,2006,29(1):27-30. 被引量:56
  • 2任明,柳茵,刘维军,李琳.慢性心力衰竭患者血浆脑利钠肽、内皮素-1水平与心功能状态的关系[J].中国现代医学杂志,2006,16(19):3023-3026. 被引量:16
  • 3Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines ( Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : Developed in Collaboration With the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation, 2005, 112: e154-e235.
  • 4Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 1988, 332: 411-415.
  • 5Ak G, Buyukberber S, Sevinc A, et al. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus. J Diabetes Complications, 2001, 15: 150-157.
  • 6Groenning BA, Raymond I, Hildebrandt PR, et al. Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population. Heart, 2004, 90 : 297- 303.
  • 7Pacher R, Stanek B, Hulsmann M, et, al. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure. J Am Coil Cardiol, 1996,27:633-641.
  • 8Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality:the Framingham Heart Study. Circulation, 2003, 107: 2920-2925.
  • 9Dupuis J, Cernacek P, Tardif JC et al. Reduced pulmonary clearance of endothelin-1 in pulmonary hypertension. Am Heart J, 1998, 135: 614-620.
  • 10Miguel R, Raquel C, Manuel P, et al. Plasma Concentration of Big Endothelin-1 and Its Relation With Plasma NT-proBNP and Ventricular Function in Heart Failure Patients. Rev Esp Cardiol, 2005, 58:278-284.

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部